Biochemistry of migraine

Area of Science:

• Biochemistry
• Neuroscience
• Clinical Medicine

Background:

• Migraine biochemistry is complex, with many unreplicated findings in small patient groups.
• Understanding migraine pathophysiology requires robust biochemical data from larger patient cohorts.
• Previous research has yielded contradictory results, necessitating a re-evaluation of key biochemical markers.

Purpose of the Study:

• To discuss well-founded observations in platelet-free plasma and urine relevant to migraine.
• To explore biochemical differences distinguishing migraine with aura, migraine without aura, and tension headache.
• To investigate the role of specific biochemical pathways in migraine predisposition and attack mechanisms.

Main Methods:

• Analysis of biochemical markers in platelet-free plasma and urine samples.
• Comparison of biochemical profiles across patient groups: migraine with aura, migraine without aura, and tension headache.
• Focus on systemic derangements, neuroexcitatory amino acids, magnesium, methionine-enkephalin, hormones, vasoactive peptides, and catecholamines.

Main Results:

• Systemic derangement of serotonin (5-HT) metabolism is linked to the peripheral vascular component of migraine.
• Changes in neuroexcitatory amino acids and magnesium suggest a predisposition to spreading depression, especially in migraine with aura.
• Alterations in methionine-enkephalin, hormonal fluctuations, vasoactive peptides, and catecholamines provide insights into migraine mechanisms and classification.

Conclusions:

• Biochemical differences exist between migraine subtypes and tension headache, particularly in plasma and urine markers.
• Serotonin metabolism, neuroexcitatory amino acids, magnesium, and vasoactive peptides are key areas for understanding migraine pathophysiology.
• These findings support the relevance of the trigemino-vascular system and sympathetic overactivity in migraine.